Let’s Begin

Select an option below and answer a few questions to help us better provide information regarding our diabetes therapies.


New to Medtronic

User new icon

Learn more about Medtronic therapies.


Get started


Current or past customer

User current icon

I’ve used a Medtronic pump before or I’m using one now.


I am looking for product support

I am looking to upgrade

What is the main goal for your therapy?

 
 
 
 
 

Please select an answer from the list above.

Depending on the type of diabetes you have and your specific needs, Medtronic offers therapy solutions that are approved for use for those as young as seven years of age.

Tell us about yourself


What type of diabetes do you have?


Note: The MiniMed™ 780G system has not been approved for use in type 2 diabetes by FDA or other regulatory bodies. Please consult your healthcare provider about which therapy is best for you.

What type of diabetes does the person you care for have?


Note: The MiniMed™ 780G system has not been approved for use in type 2 diabetes by FDA or other regulatory bodies. Please consult your healthcare provider about which therapy is best for you.

What is your current diabetes therapy?


What is the current diabetes therapy for the person you care for?


What is the brand of your insulin pump?

What brand of insulin pump do they use?

Is your healthcare provider supportive of trying a new therapy?


Is the healthcare provider of the person you care for supportive of trying a new therapy?


 Do you have any concerns with the cost of therapy?


Are there concerns about the therapy cost for the person you care for?


Explore systems that do more

Explore a system that does more

Automated Insulin Delivery System

For people who prefer an insulin pump


CGM with automated insulin pump system

Smart devices sold separately.


If you have type 1 diabetes, an insulin pump system can help prevent highs and lows with real-time insulin delivery adjustments 24/7— meaning less work for you!

With an insulin pump system, you get:

  • Easier mealtime dosing with Meal Detection™ technology†
  • Automatic adjustments and corrections every 5 minutes§
  • 96% fewer injections than daily insulin injections‡

Smart MDI System

For people who prefer insulin injections


Smart MDI System

Smart devices sold separately.


If you manage your diabetes with multiple daily injections (MDI), the smart insulin injection system can help reduce the physical and mental effort required to manage diabetes.

With a Smart MDI system, you get:

  • Insulin tracking and dose reminders
  • Dosing recommendations
  • Actionable glucose alerts

Smart MDI System

For people who prefer insulin injections


Smart MDI System

Smart devices sold separately.


If you manage your diabetes with multiple daily injections (MDI), the smart insulin injection system can help reduce the physical and mental effort required to manage diabetes.

With a Smart MDI system, you get:

  • Insulin tracking and dose reminders
  • Dosing recommendations
  • Actionable glucose alerts

Product interest request form


Thank you for your interest in Medtronic diabetes products and services. Please complete the items below so that we may provide you helpful information regarding our diabetes therapies.


* indicates fields that are required

How can we communicate with you?

† Taking a bolus 15 – 20 minutes before a meal helps to keep blood sugar levels under control after eating.
§ Refers to SmartGuard™ feature. Individual results may vary.
‡ Assumes 4 injections per day for 30 days and one infusion set change every seven days.

References
1. Adults, T1 and parents of children with T1 diabetes < 18 years were surveyed.
2. Individual results may vary.
3. dQ&A US Diabetes Patient Panel Report; Customer Overall Satisfaction, n=146; Q4 2023: P.52 (November 2023).


Important Safety Information: MiniMed™ 780G System With SmartGuard™ Technology With Guardian™ 4 Sensor
The MiniMed™ 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 780G system includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed™ 780G system consists of the following devices: MiniMed™ 780G insulin pump, the Guardian™ 4 transmitter, the Guardian™ 4 sensor, One-press serter, the Accu-Chek™ Guide Link blood glucose meter, and the Accu-Chek™ Guide test strips. The system requires a prescription from a healthcare professional.

The Guardian™ 4 sensor is intended for use with the MiniMed™ 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of diabetes. The sensor is intended for single use and requires a prescription. The Guardian™ 4 sensor is indicated for up to seven days of continuous use.

The Guardian™ 4 sensor is not intended to be used directly to make therapy adjustments while the MiniMed™ 780G is operating in manual mode. All therapy adjustments in manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ 4 sensor. The Guardian™ 4 sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Guardian™ 4 sensor in the abdomen or other body sites including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.

WARNING: Do not use the SmartGuard™ feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard™ feature.

WARNING: Do not use the MiniMed™ 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 780G system.

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard™ feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a BG meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-780g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library

Important Safety Information: InPen™
The InPen™ is a home- use reusable pen injector for single- patient use by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for the self- injection of a desired dose of insulin and for calculating an insulin dose or carbohydrate intake based on user entered data. A healthcare professional must assist in dosage programming of the device prior to use, based on various patient- specific criteria and targets. The InPen™ requires a prescription. For additional product and safety information, please consult the Instructions for Use and bit.ly/InPenRisks.

Important Safety Information: Guardian™ Connect CGM System
The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and important safety information.

Important Safety Information: i-Port Advance™ Injection Port
i-Port Advance™ injection port is indicated for patients who administer or receive multiple daily subcutaneous injections of physician prescribed medications, including insulin. The device may remain in place for up to 72 hours to accommodate multiple injections without the discomfort of additional needle sticks. i-Port Advance™ injection port may be used on a wide range of patients, including adults and children. Prescription required. For more, please see http://www.medtronicdiabetes.com/important-safety-information.

You indicated that you’re not using insulin to manage your diabetes.

Our insulin pumps are approved for the continuous delivery of insulin, so this device may not be a good fit for you at this time.

We have other resources that may be helpful for you:


If your circumstances change, please check back with us and we’d be happy to discuss therapy options that may fit your needs.

Note: The MiniMed™ 780G system has not been approved for use in type 2 diabetes by FDA or other regulatory bodies. Please consult your healthcare provider about which therapy is best for you.

Check your upgrade eligibility

Follow these three simple steps:

  • Sign into your account at Diabetes.shop/devices
  • Under Devices and products, select the “Check upgrade eligibility” button.
  • See which program you're eligible for and then submit an upgrade request!


Check eligibility or upgrade